000 | 01291 a2200373 4500 | ||
---|---|---|---|
005 | 20250517024022.0 | ||
264 | 0 | _c20161213 | |
008 | 201612s 0 0 eng d | ||
022 | _a0048-7449 | ||
024 | 7 |
_a10.4081/reumatismo.2014.799 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRossini, M | |
245 | 0 | 0 |
_aWhy golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? _h[electronic resource] |
260 |
_bReumatismo _cMar 2015 |
||
300 |
_a285-303 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aViapiana, O | |
700 | 1 | _aOrsolini, G | |
700 | 1 | _aFracassi, E | |
700 | 1 | _aIdolazzi, L | |
700 | 1 | _aGatti, D | |
700 | 1 | _aAdami, S | |
700 | 1 | _aGovoni, M | |
773 | 0 |
_tReumatismo _gvol. 66 _gno. 4 _gp. 285-303 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4081/reumatismo.2014.799 _zAvailable from publisher's website |
999 |
_c24761742 _d24761742 |